Join
Live feed
·
INSIDERFilingvia Quantisnow
Apimeds Pharmaceuticals US Inc. logo

Chief Executive Officer Emerson Erik C. was granted 750,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
APUS· Apimeds Pharmaceuticals US Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APUS (Apimeds Pharmaceuticals US Inc.) and more on Quantisnow.